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Abstract
Background: Tumorigenesis is associated with changes in gene expression and involves many
pathways. Dysregulated genes include "housekeeping" genes that are often used for normalization
for quantitative real-time RT-PCR (qPCR), which may lead to unreliable results. This study assessed
eight stages of hepatitis C virus (HCV) induced hepatocellular carcinoma (HCC) to search for
appropriate genes for normalization.
Results: Gene expression profiles using microarrays revealed differential expression of most
"housekeeping" genes during the course of HCV-HCC, including glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) and beta-actin (ACTB), genes frequently used for normalization. QPCR
reactions confirmed the regulation of these genes. Using them for normalization had strong effects
on the extent of differential expressed genes, leading to misinterpretation of the results.
Conclusion: As shown here in the case of HCV-induced HCC, the most constantly expressed
gene is the arginine/serine-rich splicing factor 4 (SFRS4). The utilization of at least two genes for
normalization is robust and advantageous, because they can compensate for slight differences of
their expression when not co-regulated. The combination of ribosomal protein large 41 (RPL41)
and SFRS4 used for normalization led to very similar results as SFRS4 alone and is a very good
choice for reference in this disease as shown on four differentially expressed genes.
Background
Cancer development affects almost all pathways and
genes [1-4]. Also affected are the so-called "housekeeping"
genes, which are involved in the cell's common basic
functions [5-8]. Typical housekeeping genes include glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH), beta-
actin (ACTB), TATA-binding protein (TBP), ribosomal
proteins (RP), and many more [9-14]. Many of these
genes are often used to normalize quantitative real-time
RT-PCR (qPCR) data [13,15,16] to account for experimen-
tal differences, such as differences in RNA quantity and
quality, the overall transcriptional activity and differences
in the cDNA synthesis. GAPDH and ACTB are most com-
monly used for normalization [17-21], including studies
on cancer [22-24]. Despite the fact that it was shown that
these genes are differentially expressed in cancers, includ-
ing colorectal-, prostate- and bladder-cancer. [6-8,25].
Some qPCR studies on hepatocellular carcinoma (HCC)
used GAPDH or ACTB for normalization [26-28].
Many investigations on cancer include multiple compari-
sons, by analyzing different stages of the disease, such as
normal tissue, pre-neoplasm, and consecutive stages of
cancer [29-32]. Such an experimental design makes it cru-
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cial to find an appropriate gene for normalization. Prereq-
uisites for normalization genes are constant expression
throughout all disease stages and no response to treat-
ment. Extensive evidence indicates that all genes can be
regulated under some conditions.
This study focuses on hepatitis C virus (HCV) induced
hepatocellular carcinoma (HCC), comprising eight path-
ological stages, including pre-neoplastic lesions (cirrhosis
and dysplasia) and four consecutive stages of HCC and
reveals that many of the 'housekeeping" genes are indeed
differentially expressed. In addition, the effects of differ-
ent reference genes used for normalization on differen-
tially expressed genes are presented and appropriate genes
useful for normalization when investigating HCV-
induced HCC are introduced.
Results
Typical "housekeeping" genes are deregulated in HCV-
induced HCC
Analyzing the expression profile of all stages of HCV-
induced HCC, including preneoplastic stages (cirrhosis
and dysplasia) and four cancerous stages with microarrays
revealed that almost all pathways were affected [4]. In
order to find normalization genes for qPCR verification,
we looked for genes that showed no differential expres-
sion in any of the eight stages analyzed. First, we selected
genes that displayed no change to controls in at least one
sample of the 72 samples included. This resulted in a list
of over 30,000 genes (Figure 1A). Among these, many
genes showed an increased expression in cancerous stages
compared to normal liver controls or were not expressed
in the liver and tumor tissues (absent call). In addition,
some genes were down-regulated in certain stages of the
disease. Hence, most of these genes were inappropriate to
be used as reference gene for normalization. In further
selection steps, we thus excluded genes that were regu-
lated or that were not expressed (absent call) in any of the
stages of the disease. This procedure led to a list of 46
genes, including 27 genes coding for ribosomal proteins
and five genes coding for splicing factors. Thus, excluding
differentially expressed genes led to only few genes that
were expressed in all stages and not changed during the
course of HCV-induced HCC: The best candidates for nor-
malization were RPL41 and SFRS4. Genes of different
pathways were chosen to exclude the possibility of co-reg-
ulation.
Furthermore, specifically checking housekeeping genes,
with functions in sugar-, nucleotide-, lipid-, amino acid-,
or energy-metabolism, or ribosomal proteins, basal tran-
scription factors and proteins of the cytoskeleton (Figure
1B), we found that most of them were either differentially
expressed during disease progression or not expressed at
all. These results display clearly that housekeeping genes
are affected in HCV-induced HCC.
Candidate reference genes from multiple comparison 
microarray data
In a different approach to identify genes appropriate for
normalization from a microarray study comprising multi-
ple comparisons we calculated the standard deviation
(SD) of all fold changes for each gene. Genes with a low
SD across all fold-changes and similar signal intensities to
the genes of interest (or present call) may provide a pool
of normalization candidates, for qPCR (see below).
Six genes were chosen as candidate reference genes for the
purpose of this study: RPL41 and SFRS4 and the com-
monly used reference genes GAPDH, ACTB and TBP, as
well as another gene coding for a ribosomal protein,
RPS20. The SD of their fold changes (microarray data)
ranks them as follows: RPL41 (0.09), ACTB (0.23), SFRS4
(0.24), TBP (0.28), GAPDH (0.34), and lastly RPS20
(0.43).
Reference genes for HCV-induced HCC
Quantitative real-time PCR (qPCR) was performed for
RPL41, SFRS4, GAPDH, ACTB, RPS20, and TBP on all tis-
sue samples. These qPCRs were performed twice (each in
triplicate), to reduce the technical variation. First, we com-
pared the SD of their Ct values (n = 72), which was lowest
for SFRS4 (0.63), followed by RPL41 (0.82), GAPDH
(0.91), TBP (1.03), ACTB (1.07), and RPS20 (1.19). For
each reaction, we calculated relative expression levels, by
subtracting the median Ct of control samples from all
other Ct values, followed by determining (1+E)-ΔCt (see
Methods). Figure 2 shows these data for the six candidate
genes for each stage of HCV-induced HCC. Notably, the
variation increases at later disease stages (early to very
advanced HCC). The coefficient of variation (CV) allows
comparison of the variation of gene-expressions inde-
pendent of their mean value. The CV was smallest for
SFRS4 (38%), followed by RPL41 (53%), ACTB (65%),
TBP (70%), GAPDH (75%), and RPS20 (94%).
Importantly, GAPDH was significantly up-regulated in
advanced stages of HCC, as calculated by the Student's t-
test (p = 0.016 control vs. very advanced HCC). Even
more obvious was the up-regulation of RPS20 during
HCC, which was already significant between control and
early HCC (p = 0.003). TBP and ACTB also showed a sig-
nificant up-regulation between control and very advanced
HCC (p = 0.014, p = 0.011, respectively).
We also used the geNorm program [13], to determine the
best normalization gene for HCV-induced HCC by step-
wise exclusion of the least stable expressed gene. The most
stably expressed genes were RPL41 and SFRS4, resulting inBMC Genomics 2007, 8:243 http://www.biomedcentral.com/1471-2164/8/243
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M = 0.65, M describing the average expression stability
(lowest for the most stably expressed genes). The expres-
sion stabilities for TBP (M = 0.74), ACTB (M = 0.78),
GAPDH (M = 0.82), and RPS20 (M = 0.88) were worse.
Hence, again, RPL41 and SFRS4 (Figure 2B) were the best
candidates for normalization of HCV-induced HCC.
Effects of different genes used for normalization
Normalization is used to adjust for experimental differ-
ences. In qPCR normalization corrects for the RNA quan-
tity, the overall transcriptional activity, the cDNA
synthesis and the PCR efficiency. Ideally, a reference gene
is an internal endogenous control, shows constant expres-
sion in the tissue under investigation and does not
respond to the experimental treatment.
Four commonly used "housekeeping" genes (GAPDH,
ACTB, RPS20, TBP1) and the combined data of RPL41
and SFRS4 (see Figure 2C) were used for normalization to
assess the effects their choice for normalization has on the
fold changes of differentially expressed genes during the
course of HCV-induced HCC.
NRG1 was identified by microarray analysis to be
decreased in cirrhosis, elevated in dysplasia, and again
down-regulated during all four stages of HCC [4]. QPCR
Common "housekeeping" genes are deregulated in HCV-induced HCC (multiple comparison microarray data) Figure 1
Common "housekeeping" genes are deregulated in HCV-induced HCC (multiple comparison microarray 
data). A) Gene expression of over 30,000 genes that showed no change to controls in at least one of 72 samples studied. B) 
323 common "housekeeping" genes whose products have functions in sugar-, nucleotide-, lipid-, amino acid-, and energy-
metabolism, or code for ribosomal proteins, basal transcription factors, and proteins of the cytoskeleton. In A) and B) the col-
umns correspond to the stages of the disease: c = control, ci = cirrhosis, dn = dysplasia, ve = very early HCC, e = early HCC, 
a = advanced HCC, and aa = very advanced HCC. Genes (in rows) were clustered using the Pearson correlation. Red indicates 
up-regulation, green down-regulation, and black no change or not expressed.BMC Genomics 2007, 8:243 http://www.biomedcentral.com/1471-2164/8/243
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was performed on NRG1 to corroborate this expression
pattern. Figure 3 shows the effects on relative NRG1
expression depending on which gene was used for nor-
malization. All genes used for normalization were roughly
able to confirm that pattern. However, the elevation of the
resulting fold changes varied greatly. The up-regulation of
NRG1 during dysplasia was much smaller, when GAPDH
was used for normalization in comparison to the other
reference genes. Similarly, the levels of down-regulation
of NRG1 during the successive stages of HCC varied
greatly dependent on the different reference genes.
HMMR was found via microarray technique to be not dif-
ferentially expressed during the precancerous stages (cir-
rhosis, low- and high-grade dysplasia), followed by a
significant increase for all HCC stages. QPCR corrobora-
tion, when normalized to RPL41 and SFRS4, GAPDH,
ACTB, RPS20 or TBP revealed similar patterns with vary-
ing fold-changes (Figure 3). However, the increase in gene
expression between high-grade dysplasia and very early
HCC was very subtle when normalized to RPS20.
In the case of PRIM1, the choice of the normalization gene
had dramatic effects on the relative gene expression.
PRIM1 was found by microarray analysis to be down-reg-
ulated during cirrhosis, dysplasia and very early HCC, fol-
lowed by increasing up-regulation in the successive stages
of HCC. The most similar expression pattern resulted
QPCR: expression of candidate genes for normalization of HCV-induced HCC Figure 2
QPCR: expression of candidate genes for normalization of HCV-induced HCC. Plotted are median fold-changes 
(relative quantification with respect to the median Ct of the control samples, corrected for PCR-efficiencies) plus minus SD for 
each stage of the disease: c = control (n = 10), ci = cirrhosis (n = 10), lg = low-grade dysplasia (n = 10), hg = high-grade dyspla-
sia (n = 7), ve = very early HCC (n = 8), e = early HCC (n = 10), a = advanced HCC (n = 7), and aa = very advanced HCC (n 
= 10). A) Expression of RPL41, GAPDH, ACTB, SFRS4, RPS20, and TBP. B) Average of the expression of RPL41 and SFRS4.BMC Genomics 2007, 8:243 http://www.biomedcentral.com/1471-2164/8/243
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when the qPCR data were normalized to the combination
of RPL41 and SFRS4 (Figure 3). The Student's t-test
showed a significant increase between dysplasia and very
early HCC (p = 0.011), confirming the significant increase
found in the microarray analysis [4]. When ACTB was
used for normalization the resulting fold changes were
less evident but the tendency was similar. In contrast, nor-
malization of PRIM1 using either GAPDH, RPS20, or
TBP1 changed the expression pattern dramatically. For
example, instead of being up-regulated, PRIM1 would be
classified as down-regulated between high-grade dyspla-
sia and very early HCC (p = 0.05, Figure 3).
A similar, albeit less dramatic effect is seen in the case of
IRAK1. IRAK1 was slightly down-regulated during the pre-
cancerous stages of HCV-induced HCC, followed by small
but significant up-regulation in HCC (Figure 3). Similar
expression pattern were found, when the two genes,
Effects of reference genes used for normalization Figure 3
Effects of reference genes used for normalization: Relative expression of NRG1, HMMR, PRIM1, and IRAK1 for all 
stages of HCV-induced HCC. QPCR data were normalized to RPL41 and SFRS4 (shown in pink), to GAPDH (yellow), to 
ACTB (light blue), to RPS20 (green), and to TBP (brown). Microarray data are shown in dark blue. Fold-changes are indicated 
on the y-axis. Disease stages as in Figure 2. The table shows p-values for the change in gene expression from high-grade dyspla-
sia to very early HCC for NRG1, HMMR, PRIM1, and IRAK1 (rows) when normalized to the genes indicated above (columns). 
Significant (p ≤ 0.5) up-regulation between these stages is indicated in red, down-regulation in green.BMC Genomics 2007, 8:243 http://www.biomedcentral.com/1471-2164/8/243
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RPL41 and SFRS4 were used for normalization. Again,
GAPDH, RPS20 and TBP changed even the tendency of
the expression of IRAK1 in HCC.
These results clearly demonstrate the effects genes used for
normalization have on the fold change of qPCR data and
on the general direction (up or down) of differentially
expressed genes.
Discussion
The most commonly used reference genes for normaliza-
tion of qPCR data are GAPDH and ACTB [17-24]. How-
ever, these genes can be significantly differentially
expressed as shown in our study in HCV-induced HCC.
GAPDH was strongly up-regulated in advanced and very
advanced stages of HCC, in some samples up to 7-fold.
ACTB was up-regulated two- to three-fold in many
advanced and very advanced HCC samples. Also, ribos-
omal proteins should be considered individually, because
many of them, e.g. RPS20 were differentially expressed
during HCV-induced HCC [4], while RPL41 showed a rel-
ative stable expression throughout all stages of the dis-
ease.
It was reported that GAPDH and ACTB were also differen-
tially expressed in other cancer types [8,14,33]. In bladder
cancer, a study showed that GAPDH, G6PD and HMBS
were significantly changed between malignant and non-
malignant tissues [25]. Similarly, in adenocarcinomas of
the colon, the expression of RPLP0, RPS14 and GAPDH
varied between primary tumors and corresponding resec-
tion margins [34]. Furthermore, in prostate cancer, ACTB,
RPL13A and HMBS showed significant differences
between cancer and noncancerous tissues [6]. Taken
together, genes whose products have basic functions in
cellular metabolisms are possibly differentially expressed
between tumor and non-tumor tissues.
Normalization is used to adjust for experimental differ-
ences. This study presents an easy way to find appropriate
candidates for normalization utilizing microarray data,
also applicable to multiple comparisons. A pool of candi-
date genes can be found by selecting genes with low SD
across all fold-changes and with similar signal intensity to
the genes of interest (at least a present call). This identified
the same best candidate, RPL41, as the procedure, in
which differentially expressed genes were excluded.
We compared the qPCR data of six possible reference
genes. The SD of the Ct values indicated that SFRS4 and
RPL41 may be the best choice to be used for normaliza-
tion. This was confirmed on the level of fold-changes,
when we compared the CVs. Furthermore, the Student's t-
test revealed that GAPDH, RPS20, TBP and ACTB were sig-
nificantly regulated between certain stages of HCV-
induced HCC. Consistent with these data, the geNorm-
program also determined that SFRS4 and RPL41 were the
most stable expressed genes. Using Normfinder [35], an
additional computer program, aimed at identifying nor-
malization genes, TBP was the best choice for normaliza-
tion. However, we showed that TBP was significantly
regulated between control and advanced HCC. In our sit-
uation, Normfinder was thus unable to identify the best
normalization gene.
The effects of six genes used for normalization were com-
pared on four differentially expressed genes: NRG1,
HMMR, PRIM1, and IRAK1. In contrast to NRG1 and
HMMR, where the resulting fold changes were over- and
underestimated, depending on the gene used for normal-
ization dramatic effects were found for the differentially
expression of PRIM1 and IRAK1. Normalization using an
inappropriate gene could lead to misinterpretation of the
data, as it was shown for GAPDH, RPS20 or TBP in the
context of HCV-induced HCC. Robust results were
achieved by using two genes, RPL41 and SFRS4 in combi-
nation for normalization. Using at least two genes to nor-
malize qPCR data has the advantages that they can
compensate for slight differences in their expression. To
profit most, these normalization genes should participate
in different pathways.
This study, unlike many cancer studies, which compare
tumor versus nontumor, comprised eight stages of HCV-
induced HCC. Even though we included 72 tissue samples
[4], each stage was only represented with seven to ten
samples. This small sample size might be a limitation of
the study design when performing statistical tests, such as
t-tests between the stages. In order, to find the best nor-
malization gene however, all samples were considered
independent of their stage group.
Microarray data are known to be highly variable [36-41].
Due to its higher dynamic range qPCR, is thought to be
more accurate and therefore is often used to corroborate
microarray results [42,43]. Mostly, general direction (up-
and down-regulation) and rank order of the fold-changes
are similar, but the levels of the fold changes of microarray
experiments differ compared to qPCR data [44-46] and
show a marked tendency of being smaller [42,44,46]. This
effect is more pronounced as the fold change ratio is very
high [42].
This study shows the effects of reference genes used for
normalization on qPCR data. The use of inappropriate
genes for normalization can lead to an over- or under-esti-
mation of the fold-changes or to misinterpretation of the
results. The best results were achieved when the two genes
RPL41 and SFRS4 were used for normalization.BMC Genomics 2007, 8:243 http://www.biomedcentral.com/1471-2164/8/243
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Conclusion
Many pathways are affected by cancer, as recently shown
for HCC. Therefore, typical housekeeping genes or main-
tenance genes are likely to be differentially expressed dur-
ing the course of the disease.
Appropriate genes for normalization should show a con-
stant expression throughout all comparisons, they should
be expressed in similar abundance as differentially
expressed genes, and should not respond to the experi-
mental treatment. From microarray experiments, genes,
which display stable expression across all fold-changes are
likely to be good candidates for normalization for qPCR.
The utilization of at least two genes for normalization is
highly recommended and will lead to the most reliable
and accurate results.
In HCV-induced HCC the combination of RPL41 and
SFRS4 were best to normalize qPCR data.
Methods
Tissue samples and microarray data
Tissue samples of this manuscript were described in [4].
To analyze hepatitis C virus (HCV) induced hepatocellu-
lar carcinoma (HCC) 72 tissue samples, including normal
liver tissue (n = 10), cirrhotic liver tissue (n = 10), dysplas-
tic nodules [low- (n = 10) and high-grade (n = 7)] and
four successive stages of HCC [(from very early HCC to
metastatic tumors with gross vascular invasion (n = 35)]
were used to generate gene expression profiles by utilizing
the human GeneChip whole genome array (U133 Plus
2.0 from Affymetrix). Data were normalized applying the
GC Robust Multi-array Average (GC-RMA) algorithm and
the baseline was calculated by the geometric mean using
the data generated from 10 normal liver tissue samples
(up- and down-regulation refers to the comparison with
this baseline). Significant analysis of microarray (SAM)
data was performed in GeneTraffic (Stratagene, La Jolla,
CA). The microarray data are available at GEO (GSE
6764).
RNA extraction
The tissue specimen were ground in liquid nitrogen and
homogenized in Trizol (Invitrogen, Carlsbad, CA) using a
polytron homogenizer. Total RNA was purified following
the RNeasy Mini protocol (Qiagen, Valencia, CA), includ-
ing a DNaseI digestion, to avoid contamination with
genomic DNA. 28S/18S ratios measured with the Bioana-
lyzer (Agilent Technologies, Palo Alto, CA) had to be
higher than 0.8 to be included into the study. Further
quality criteria of the samples to be included into the
study are described in detail elsewhere [4].
QPCR
5 μg total, DNaseI treated RNA was reverse transcribed
into cDNA using oligo dT and Superscript III (Invitrogen,
Carlsbad, CA), followed by RNaseH digestion. The cDNA
was diluted 1:100 and 5 μl were used as template in a 10
μl qPCR reaction. The qPCR assays were performed as
described previously [43], using SYBR Green (Molecular
Probes, Eugene, OR) and Platinum Taq (Invitrogen,
Carlsbad, CA) on the ABI Prism 7900 (Applied Biosys-
tems, Foster City, CA). Primers were designed using the
Primer3 software [47]. The following primers were used:
GAPDH (NM_002046) cga cca ctt tgt caa gct ca (sense)
and agg ggt cta cat ggc aac tg (antisense); ACTB
(NM_001101) gga ctt cga gca aga gat gg (sense) and agc
act gtg ttg gcg tac ag (antisense); TBP1 (NM_003194) tat
aat ccc aag cgg ttt gc (sense) and cac agc tcc cca cca tat tc
(antisense), RPL41 (NM_021104) aag atg agg cag agg tcc
aa (sense) and tcc aga atg tca cag gtc ca (antisense); SFRS4
(NM_005626) aaa agt cgg agc agg agt ca (sense) and ctc ttc
ctg ccc ttc ctc tt (antisense); RPS20 (NM_001023) aac aag
ccg caa cgt aaa at (sense) and gga aac gat ccc acg tct ta (anti-
sense); PRIM1 (NM_000946) gcc ata cgc atc att gac ag
(sense) and cca ccc ttt aca agg ctc aa (antisense); NRG1
(NM_004495) gcc tct gcc aat atc acc at (sense) and act ccc
ctc cat tca cac ag (antisense); IRAK1 (NM_001569) gct ctt
tgc cca tct ctt tg (sense) and gct acc acg cca ggc taa ta (anti-
sense); and HMMR (NM_012485) tgc agc tca gga aca gct
aa (sense) and caa gct gac agc gga gtt tt (antisense). Ampli-
con size and reaction specificity were confirmed by agar-
ose gel electrophoresis and melting curve analysis. The
PCR was performed after activation of the enzyme 95°C
for 120s, for 40 cycles of: 95°C for 15s, 56°C for 15s and
72°C for 30s. The PCR reaction was followed by a disso-
ciation curve 95°C for 15s, 60°C for 15s, 95°C for 15s
(ramp 2%). All PCR reactions were performed in tripli-
cate.
Data analyses
The raw data were analyzed using SDS2.2 (Applied Bio-
systems, Foster City, CA) by subtraction the background
and setting the threshold to obtain the Ct-value. PCR effi-
ciencies (E) were calculated by using dilution series and
the formula E = 10(-1/slope)-1. The efficiencies for the fol-
lowing PCRs were: GAPDH 0.89, ACTB 0.92, TBP 0.89,
RPL41 0.78, SFRS4 0.94, RPS20 0.87, PRIM1 0.89, NRG1
0.97, IRAK1 0.96, and HMMR 0.89. All fold-changes were
calculated based on these efficiencies. Further analyses
were done in Excel: the median Ct was taken from tripli-
cate reactions and compared to the median of all normal
tissue samples, results are expressed as fold-changes. The
qPCR reactions for RPL41, SFRS4, GAPDH, ACTB, RPS20,
and TBP were done twice (in triplicates), independently to
reduce the technical variation. The significance of differ-
ential expression was calculated by using the t-test inBMC Genomics 2007, 8:243 http://www.biomedcentral.com/1471-2164/8/243
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Excel. The geNorm analysis was performed as described in
the manual [13]. Normfinder was used as in [48].
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